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CASE HISTORY
A 51-year-old male former smoker, without relevant 
medical history, had progressive dyspnea on exertion, cough, 
minor hemoptysis, and a large suprahilar tumor-like mass on 
chest radiography. A positron emission tomography–computed 
tomography scan at the referring center showed a lobulated mass 
invading the mediastinum and right pulmonary artery, and filling 
defects suspect for pulmonary emboli (Fig. 1). The lesion had 
moderate 18F-fluorodeoxyglucose uptake. At bronchoscopy, the 
right upper lobe was suboccluded by a smooth mass. Forceps 
biopsies revealed necrosis of unclear origin. The patient was 
referred for workup.
The absence of venous thrombosis, intracardiac clots, 
pulmonary hypertension, and arterial hypoxemia reduced the 
likelihood of widespread pulmonary emboli. After reassess-
ment at our thoracic oncology multidisciplinary meeting, a 
surgical procedure was proposed based on the suspicion of a 
tumor mass originating from the pulmonary artery.
A right-sided intrapericardial pneumonectomy and 
 left-sided pulmonary endarterectomy (PEA) through ster-
notomy was performed on extracorporal cardiopulmonary 
bypass. The procedure and postoperative recovery were 
uncomplicated. The pneumonectomy specimen showed a 
tumor completely obliterating the right pulmonary artery and 
protruding into the right upper lobe bronchi. Left PEA from 
pulmonary valve level to the subsegmental branches was able 
to remove a pale smooth mass (Fig. 2).
Pathology showed a tumor in the pulmonary artery wall 
with a heterogeneous aspect. Essentially, it concerns a spindle 
cell process with cellular fascicular to myxoid areas. The tumor 
cell nuclei were atypical with a mitotic count of 5 of 10 hpf. 
Immunohistochemistry revealed (nuclear) MDM2 expression 
and diffuse epidermal growth factor receptor expression (Fig. 3). 
Stains for desmin, α-smooth muscle actin, CD31, and CD34 
were negative. FISH analysis showed strong amplification of the 
MDM2 and PDGFRA genes, thus confirming an intima sarcoma.
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FIGURE 1.  Transaxial chest computed tomography images  
(A) show a mass invading the right pulmonary artery and medias-
tinum and a central filling defect in the proximal left pulmonary 
artery (arrow). The mass had moderate 18F-fluorodeoxyglucose 
uptake on positron emission tomography (B).
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DISCUSSION
Pulmonary artery intimal sarcoma (PAIS) is a very rare 
thoracic malignancy, first described in an autopsy in 1923, 
with an estimated incidence between 0.001% and 0.03%. 
PAIS often presents as pulmonary vascular disease, such as 
acute pulmonary embolism,1 chronic thromboembolic pulmo-
nary hypertension, and idiopathic pulmonary artery hyperten-
sion,2 and it can even mimic large-vessel arteritis.3 Diagnosis 
FIGURE 3.  Histopathological examination. Low 
power view (A) showing the tumor nodules in the 
arterial branches (arrows), and at higher mag-
nification (B), a moderately cellular spindle cell 
proliferation is present. Immunohistochemistry 
showing nuclear MDM2 expression (C) and 
strong cytoplasmic epidermal growth factor 
receptor labeling (D).
FIGURE 2.  Resection specimen showing tumor occluding the right pulmonary artery (A) and a pale pulmonary artery cast 
after left pulmonary endarterectomy (B).
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is challenging, and FISH analysis by experienced pathologists 
is essential in identifying PAIS.
Less than 300 cases are described in the literature, with 
only a few small case series focusing on the management of 
these tumors. Median survival is 45 days, up to 10 months 
with surgery.4 Survival is worse in aortic intima sarcoma. In 
the recently published largest single-center series (31 patients), 
postsurgical median survival was 17 months.5 Death is mostly 
because of local or metastatic recurrence. PEA is often per-
formed for PAIS, solely or in combination with pneumonec-
tomy. Evaluation of completeness of resection is complicated. 
The role of adjuvant chemotherapy or radiotherapy is unclear 
because of limited data.
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